DCVC Bio invests in early stage deep tech startups in the life sciences. These include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies.
We are scientists and entrepreneurs supporting companies advancing basic science, generating biological data, iterating with artificial intelligence, and automation. We like teams whom are unifying data to transform existing life sciences technologies, and speed the development of new ones.
Learn more about us at www.dcvc.com, read our blog at www.medium.com/@dcvc, and follow us on Twitter at @DCVCBio.
Learn more about us at www.dcvc.com/bio/, read our blog at www.medium.com/@dcvc, and follow us on Twitter at @DCVCBio.
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies have included 10X Genomics, Apple Computer, AveXis, Check Point Software, CloudFlare, Dollar Shave Club, Gilead Sciences, Idec Pharma, Illumina, Intel, Millennium Pharma and Nest. For more information, please visit Venrock’s website at www.venrock.com and follow the firm on X at @venrock.